Therapeutic effect of targeted Fas-expressing adenoviruses method combining γδ T cells in a mouse model of human ovarian carcinoma

  • Authors:
    • Dingyuan Zeng
    • Jiajing Lin
    • Hongying He
    • Guangping Tan
    • Ying Lan
    • Fuyan Jiang
    • Shuting Sheng
  • View Affiliations

  • Published online on: December 13, 2017     https://doi.org/10.3892/ol.2017.7599
  • Pages: 2555-2561
Metrics: HTML 0 views | PDF 0 views     Cited By (CrossRef): 0 citations

Abstract

The present study aimed to investigate the therapeutic effect and safety of targeted use of Fas‑expressing adenoviruses combined with γδ T cell‑mediated killing to treat human ovarian cancer xenografts in BALB/c mice. Shuttle plasmids containing control elements of human telomerase reverse transcriptase promoter and two‑step transcriptional amplification system were constructed and packaged into adenovirus‑5 vectors to generate expression of an exogenous Fas gene. A mouse xenograft model of human ovarian carcinoma was constructed. A total of 35 BALB/c mice were randomly divided into five groups, which were injected with PBS, γδ T cells, Fas‑expressing adenoviruses, taxol, or Fas‑expressing adenovirus and γδ T cells. The weight and volume of tumors in mice in each group was monitored. Tissue sections of the various tissues of mice in the Fas‑expressing adenovirus and γδ T cells group was compared with those in the PBS group to evaluate the safety of Fas‑expressing adenovirus and γδ T cells in the treatment of human ovarian cancer xenograft tumors. The results of the present study indicated that mice in all treatment groups were alive at the end of the treatment course. Tumor weight and volume was the highest in the PBS group, followed successively by the adenovirus group, the γδ T cell group, the adenovirus and γδ T cell group, and the taxol group. The weight and volume inhibition rate in adenovirus and γδ T cell group were significantly higher compared with in the PBS group (P<0.05). Pathological observation of tissue samples revealed that none of vital organs in the adenovirus and γδ T cell group developed any evident morphological changes during treatment, when compared with healthy controls. In conclusion, the combined therapy with Fas‑expressing adenoviruses and γδ T cells is efficient and safe for the treatment of mouse human ovarian carcinoma xenografts.

Related Articles

Journal Cover

February 2018
Volume 15 Issue 2

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Zeng, D., Lin, J., He, H., Tan, G., Lan, Y., Jiang, F., & Sheng, S. (2018). Therapeutic effect of targeted Fas-expressing adenoviruses method combining γδ T cells in a mouse model of human ovarian carcinoma. Oncology Letters, 15, 2555-2561. https://doi.org/10.3892/ol.2017.7599
MLA
Zeng, D., Lin, J., He, H., Tan, G., Lan, Y., Jiang, F., Sheng, S."Therapeutic effect of targeted Fas-expressing adenoviruses method combining γδ T cells in a mouse model of human ovarian carcinoma". Oncology Letters 15.2 (2018): 2555-2561.
Chicago
Zeng, D., Lin, J., He, H., Tan, G., Lan, Y., Jiang, F., Sheng, S."Therapeutic effect of targeted Fas-expressing adenoviruses method combining γδ T cells in a mouse model of human ovarian carcinoma". Oncology Letters 15, no. 2 (2018): 2555-2561. https://doi.org/10.3892/ol.2017.7599